JP2016510326A5 - - Google Patents

Download PDF

Info

Publication number
JP2016510326A5
JP2016510326A5 JP2015553856A JP2015553856A JP2016510326A5 JP 2016510326 A5 JP2016510326 A5 JP 2016510326A5 JP 2015553856 A JP2015553856 A JP 2015553856A JP 2015553856 A JP2015553856 A JP 2015553856A JP 2016510326 A5 JP2016510326 A5 JP 2016510326A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
treatment
compound
cardiovascular disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015553856A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016510326A (ja
JP6449171B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/012085 external-priority patent/WO2014113696A1/en
Publication of JP2016510326A publication Critical patent/JP2016510326A/ja
Publication of JP2016510326A5 publication Critical patent/JP2016510326A5/ja
Application granted granted Critical
Publication of JP6449171B2 publication Critical patent/JP6449171B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015553856A 2013-01-18 2014-01-17 治療指数の改善されたニトロキシル供与体 Expired - Fee Related JP6449171B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361754237P 2013-01-18 2013-01-18
US61/754,237 2013-01-18
US201361782781P 2013-03-14 2013-03-14
US61/782,781 2013-03-14
PCT/US2014/012085 WO2014113696A1 (en) 2013-01-18 2014-01-17 Nitroxyl donors with improved therapeutic index

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2017005276A Division JP6311038B2 (ja) 2013-01-18 2017-01-16 治療指数の改善されたニトロキシル供与体
JP2018228317A Division JP6656345B2 (ja) 2013-01-18 2018-12-05 治療指数の改善されたニトロキシル供与体

Publications (3)

Publication Number Publication Date
JP2016510326A JP2016510326A (ja) 2016-04-07
JP2016510326A5 true JP2016510326A5 (https=) 2017-02-23
JP6449171B2 JP6449171B2 (ja) 2019-01-09

Family

ID=50064795

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015553856A Expired - Fee Related JP6449171B2 (ja) 2013-01-18 2014-01-17 治療指数の改善されたニトロキシル供与体
JP2015553858A Expired - Fee Related JP6533159B2 (ja) 2013-01-18 2014-01-17 ニトロキシル供与体を含む医薬組成物
JP2017005276A Expired - Fee Related JP6311038B2 (ja) 2013-01-18 2017-01-16 治療指数の改善されたニトロキシル供与体
JP2018228317A Active JP6656345B2 (ja) 2013-01-18 2018-12-05 治療指数の改善されたニトロキシル供与体
JP2019096869A Expired - Fee Related JP6801045B2 (ja) 2013-01-18 2019-05-23 ニトロキシル供与体を含む医薬組成物

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2015553858A Expired - Fee Related JP6533159B2 (ja) 2013-01-18 2014-01-17 ニトロキシル供与体を含む医薬組成物
JP2017005276A Expired - Fee Related JP6311038B2 (ja) 2013-01-18 2017-01-16 治療指数の改善されたニトロキシル供与体
JP2018228317A Active JP6656345B2 (ja) 2013-01-18 2018-12-05 治療指数の改善されたニトロキシル供与体
JP2019096869A Expired - Fee Related JP6801045B2 (ja) 2013-01-18 2019-05-23 ニトロキシル供与体を含む医薬組成物

Country Status (29)

Country Link
US (13) US8987326B2 (https=)
EP (5) EP3284463B1 (https=)
JP (5) JP6449171B2 (https=)
KR (2) KR102177899B1 (https=)
CN (4) CN105142627B (https=)
AU (5) AU2014207408C1 (https=)
BR (2) BR112015017241B1 (https=)
CA (2) CA2898445C (https=)
CY (3) CY1120535T1 (https=)
DK (3) DK2945621T3 (https=)
ES (4) ES2882279T3 (https=)
HK (1) HK1251170B (https=)
HR (3) HRP20180121T1 (https=)
HU (3) HUE036589T2 (https=)
IL (4) IL239906B (https=)
LT (3) LT3284463T (https=)
MX (2) MX363843B (https=)
NZ (4) NZ748771A (https=)
PL (3) PL2945621T3 (https=)
PT (3) PT2945620T (https=)
RS (3) RS56968B1 (https=)
RU (3) RU2684916C2 (https=)
SG (6) SG11201505568PA (https=)
SI (3) SI2945621T1 (https=)
SM (3) SMT201900027T1 (https=)
TR (1) TR201802211T4 (https=)
TW (3) TWI619491B (https=)
WO (2) WO2014113700A1 (https=)
ZA (2) ZA201505090B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0708804B8 (pt) 2006-03-17 2021-05-25 Cardioxyl Pharmaceuticals Inc compostos derivados de n-hidroxilsulfonamida como doadores de nitroxil, composição farmacêutica e kit
AU2013201929B2 (en) 2011-10-17 2015-07-23 The Johns Hopkins University N-substituted hydroxylamine derivatives with carbon-based leaving groups
HRP20180121T1 (hr) 2013-01-18 2018-02-23 Cardioxyl Pharmaceuticals Inc. Donori nitroksila s poboljšanim terapijskim indeksom
EP3126329B1 (en) 2014-01-17 2019-05-29 Cardioxyl Pharmaceuticals Inc. N-hydroxymethanesulfonamide nitroxyl donors
US9464061B2 (en) 2014-05-27 2016-10-11 The Johns Hopkins University N-hydroxylamino-barbituric acid derivatives
EP3148972B1 (en) 2014-05-27 2019-08-21 Cardioxyl Pharmaceuticals, Inc. Pyrazolone derivatives as nitroxyl donors
US10456405B2 (en) 2015-09-07 2019-10-29 Zhejiang Huahai Pharmaceutical Co., Ltd Nitric oxide-releasing prodrug molecule of substituted quinazolines
US10730828B2 (en) 2015-10-19 2020-08-04 Cardioxyl Pharmaceuticals, Inc. N-hydroxylsulfonamide derivatives as nitroxyl donors
KR20180063326A (ko) 2015-10-19 2018-06-11 카르디옥실 파마슈티칼스 인코포레이티드 니트록실 공여자로서의 피라졸론 유도체
US10913728B2 (en) 2016-07-28 2021-02-09 The Johns Hopkins University O-substituted hydroxamic acids
US11083704B2 (en) 2017-01-03 2021-08-10 Bristol-Myers Squibb Company Method of administering nitroxyl donating compounds
CN110536682B (zh) * 2017-04-18 2023-01-06 基恩菲特公司 依拉非诺或其衍生物与抗nash、抗纤维化或抗胆汁淤积药剂的组合
CN116283762B (zh) * 2023-03-28 2025-08-12 昆山市第一人民医院 一种用于制备白鲜碱的中间体化合物及其制备方法、白鲜碱的制备方法
WO2025043108A1 (en) 2023-08-23 2025-02-27 Bristol -Myers S Quibb Company Co-crystals of nitroxyl donating compounds

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1017976A (en) 1911-08-25 1912-02-20 Rudolph Koch Automatic mail-bag catcher and deliverer.
US1021340A (en) 1911-10-14 1912-03-26 William A Scott Means for attaching binding-posts to dry batteries.
US3751255A (en) 1972-03-24 1973-08-07 Eastman Kodak Co Photosensitive and thermosensitive element, composition and process
JPS567710A (en) 1979-06-28 1981-01-27 Sansho Seiyaku Kk Whitening cosmetic
US4539321A (en) 1981-10-26 1985-09-03 William H. Rorer, Inc. 5-Diaza-aryl-3-substituted pyridone compounds
DE3583799D1 (de) 1985-01-11 1991-09-19 Abbott Lab Ltd Feste zubereitung mit langsamer freisetzung.
US4663351A (en) 1985-08-23 1987-05-05 Berlex Laboratories, Inc. Dobutamine tri-isobutyric acid ester and the use thereof as a cardiotonic agent
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
JPH01221371A (ja) 1988-02-29 1989-09-04 Hokko Chem Ind Co Ltd 環状オキシアミン誘導体の製造方法
JPH01221372A (ja) 1988-03-01 1989-09-04 Hokko Chem Ind Co Ltd 環状アシルヒドロキシルアミン誘導体
JPH0221372A (ja) 1988-07-08 1990-01-24 Sharp Corp はんだ付検査装置
JPH0828240B2 (ja) 1990-05-25 1996-03-21 矢崎総業株式会社 電線相互の圧着接続構造及び圧着接続方法
JP2773959B2 (ja) 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
JPH04321671A (ja) 1991-04-17 1992-11-11 Mitsubishi Petrochem Co Ltd カルバモイルトリアゾール誘導体およびそれを有効成分とする除草剤
KR970700646A (ko) * 1994-01-19 1997-02-12 헤르베르트 루프·울리히 볼프 니트록시기를 포함한 벤질아민 유도체, 및 심장 혈관 질환과 안압 상승의 치료를 위한 이의 용도(nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure)
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
JPH10142729A (ja) 1996-11-05 1998-05-29 Fuji Photo Film Co Ltd 熱現像画像記録材料
KR20010031319A (ko) 1997-10-24 2001-04-16 요시히코 시오노 항류마티스제
SI0930302T1 (en) 1998-01-16 2003-10-31 F. Hoffmann-La Roche Ag Benzosulfone derivatives
AU4333799A (en) 1998-06-04 1999-12-20 Board Of Regents, The University Of Texas System Digital optical chemistry micromirror imager
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
DE69924735T2 (de) 1998-07-28 2006-01-19 Tanabe Seiyaku Co., Ltd. Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
JP2002072459A (ja) 2000-08-28 2002-03-12 Toyo Gosei Kogyo Kk 光酸発生剤及びそれを含有する感光性樹脂組成物
HUP0303857A3 (en) * 2000-12-13 2007-07-30 Wyeth Corp Heterocyclic sulifonamide inhibitors of beta amyloid production
EP1219306A1 (en) 2000-12-29 2002-07-03 Nicox S.A. Compositions comprising cyclodextrins and NO- releasing drugs
GB0114223D0 (en) 2001-06-12 2001-08-01 Ici Plc Catalytic oxidation process
US20040038947A1 (en) 2002-06-14 2004-02-26 The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services Method of treating ischemia/reperfusion injury with nitroxyl donors
US6936639B2 (en) 2002-08-21 2005-08-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitroxyl progenitors in the treatment of heart failure
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
WO2005061519A1 (en) 2003-12-19 2005-07-07 Takeda San Diego, Inc. Kinase inhibitors
CA2554771A1 (en) 2004-01-30 2005-08-18 Johns Hopkins University Nitroxyl progenitor compounds and methods of use
EP1846439A2 (en) 2005-01-31 2007-10-24 The Johns Hopkins University Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
EP1909779A1 (en) 2005-06-23 2008-04-16 Johns Hopkins University Thiol-sensitive positive inotropes
BRPI0708804B8 (pt) 2006-03-17 2021-05-25 Cardioxyl Pharmaceuticals Inc compostos derivados de n-hidroxilsulfonamida como doadores de nitroxil, composição farmacêutica e kit
EP2010476A4 (en) 2006-04-13 2011-01-26 Univ Wake Forest Health Sciences NITROXYL DISPENSERS FROM C-NITROSO COMPOUNDS
NZ584036A (en) 2007-09-26 2012-06-29 Univ Johns Hopkins N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
LT2278975T (lt) 2008-05-07 2016-11-25 Cardioxyl Pharmaceuticals Inc. Nauji nitrozo junginiai kaip nitroksilo donorai, ir jų panaudojimo būdas
WO2011063339A1 (en) * 2009-11-23 2011-05-26 Cardioxyl Pharmaceuticals, Inc. Nitroxyl donors for the treatment of pulmonary hypertension
US20110144067A1 (en) 2009-12-07 2011-06-16 Toscano John P N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives
WO2011071947A2 (en) 2009-12-07 2011-06-16 Johns Hopkins University Bis-acylated hydroxylamine derivatives
AU2013201929B2 (en) 2011-10-17 2015-07-23 The Johns Hopkins University N-substituted hydroxylamine derivatives with carbon-based leaving groups
WO2014070919A1 (en) 2012-11-01 2014-05-08 The Johns Hopkins University Controlled hno release through intramolecular cyclization-elimination
HRP20180121T1 (hr) 2013-01-18 2018-02-23 Cardioxyl Pharmaceuticals Inc. Donori nitroksila s poboljšanim terapijskim indeksom
EP3126329B1 (en) 2014-01-17 2019-05-29 Cardioxyl Pharmaceuticals Inc. N-hydroxymethanesulfonamide nitroxyl donors
US9464061B2 (en) 2014-05-27 2016-10-11 The Johns Hopkins University N-hydroxylamino-barbituric acid derivatives

Similar Documents

Publication Publication Date Title
JP2016510326A5 (https=)
JP2019524883A5 (https=)
JP2015057451A5 (https=)
RU2017105353A (ru) Соединения
JP2016518337A5 (https=)
JP2013519675A5 (https=)
JP2016528301A5 (https=)
JP2014077003A5 (https=)
CN110036005A (zh) 酰胺衍生物及其在药物中的应用
JP2013542247A5 (https=)
JP2017537066A5 (https=)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
JP2016511753A5 (https=)
JP2016539157A5 (https=)
JP2015510916A5 (https=)
JP2016027060A5 (https=)
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
JP2015516419A5 (https=)
JP2013166781A5 (https=)
JP2017505809A5 (https=)
RU2015135824A (ru) Бициклические соединения пиримидона в качестве ингибиторов lp-pla2
WO2016057658A8 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
JP2016515550A5 (https=)
JP2016532632A5 (https=)
RU2016112257A (ru) Композиция для лечения гипертензии и/или фиброза